Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease
Authors:
- 30 September 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (11) , 1206-1215
Abstract
Background: In some lysosomal storage diseases, considerable alterations of the central nervous system (CNS) occur prior to birth and neurodegeneration progresses rapidly soon after birth causing early death in patients. No effective treatment is available after birth. Treatment may need to be initiated before birth to prevent the onset or progression of neurological changes and thereby irreversible brain damage. The aim of this study is to investigate the feasibility and effectiveness of brain‐directed prenatal gene therapy for lysosomal storage diseases.Methods: Recombinant adenovirus encoding the lacZ gene was injected into the lateral ventricles of mouse embryos and the pattern of gene transduction to the CNS was investigated. In the therapeutic experiment, adenovirus expressing β‐glucuronidase was injected into the cerebral ventricles of the embryos of mucopolysaccharidosis VII mice and the therapeutic effects on the brain were evaluated.Results: Injection of adenoviral vectors to the cerebral ventricles of mouse embryos led to widespread gene transduction throughout the brain and the spinal cord and transgene expression persisted over 10 months in those surviving the procedure. The prenatal transduction of the therapeutic gene to the brain of the mucopolysaccharidosis VII mouse efficiently prevented lysosomal storage in most brain cells before birth until 4 months after birth.Conclusions: Brain‐directed in utero gene therapy through an intra‐ventricular route would be an effective strategy to treat some lysosomal storage diseases with early and severe CNS alterations. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 38 references indexed in Scilit:
- Ultrasound-Guided Percutaneous Delivery of Adenoviral Vectors Encoding the β -Galactosidase and Human Factor IX Genes to Early Gestation Fetal Sheep In UteroHuman Gene Therapy, 2003
- Fetal Hematopoietic Stem Cell Transplantation: A Challenge for the Twenty-First CenturyJournal of Hematotherapy & Stem Cell Research, 2002
- Absence of Metabolic Cross-correction in Tay-Sachs CellsJournal of Biological Chemistry, 2002
- Glucosylsphingosine Accumulation in Mice and Patients with Type 2 Gaucher Disease Begins Early in GestationPediatric Research, 2000
- Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in uteroSurgery, 1999
- In Utero Gene Therapy: Transfer and Long-Term Expression of the Bacterial neo r Gene in Sheep after Direct Injection of Retroviral Vectors into Preimmune FetusesHuman Gene Therapy, 1998
- Biosynthesis and Intracellular Targeting of the CLN3 Protein Defective in Batten DiseaseHuman Molecular Genetics, 1998
- In utero gene transfer into the pulmonary epitheliumNature Medicine, 1995
- Microglia: The Effector Cell for Reconstitution of the Central Nervous System following Bone Marrow Transplantation for Lysosomal and Peroxisomal Storage DiseasesCell Transplantation, 1995
- Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo.Journal of Clinical Investigation, 1995